These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 12892863)

  • 1. Correction: Digital and precision clinical trials: innovations for testing mental health medications, devices, and psychosocial treatments.
    Lenze E; Torous J; Arean P
    Neuropsychopharmacology; 2024 Jan; 49(1):298. PubMed ID: 37783841
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of Integrated Social Cognitive Remediation vs. Neurocognitive Remediation in Improving Functional Outcome in Schizophrenia: Concept and Design of a Multicenter, Single-Blind RCT (The ISST Study).
    Wölwer W; Frommann N; Lowe A; Kamp D; Weide K; Bechdolf A; Brockhaus-Dumke A; Hurlemann R; Muthesius A; Klingberg S; Hellmich M; Schmied S; Meyer-Lindenberg A;
    Front Psychiatry; 2022; 13():909370. PubMed ID: 35800017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Feasibility and Efficacy of Social Cognition and Interaction Training for Outpatients With Schizophrenia in Japan: A Multicenter Randomized Clinical Trial.
    Kanie A; Kikuchi A; Haga D; Tanaka Y; Ishida A; Yorozuya Y; Matsuda Y; Morimoto T; Fukuoka T; Takazawa S; Hagiya K; Ozawa S; Iwata K; Ikebuchi E; Nemoto T; Roberts DL; Nakagome K
    Front Psychiatry; 2019; 10():589. PubMed ID: 31507463
    [No Abstract]   [Full Text] [Related]  

  • 4. Attitudes towards antipsychotics among patients with schizophrenia on first- or second-generation medications.
    Karthik MS; Warikoo N; Chakrabarti S; Grover S; Kulhara P
    Indian J Psychol Med; 2014 Jul; 36(3):288-93. PubMed ID: 25035553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A theory of behaviour on progressive ratio schedules, with applications in behavioural pharmacology.
    Bradshaw CM; Killeen PR
    Psychopharmacology (Berl); 2012 Aug; 222(4):549-64. PubMed ID: 22752382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of second-generation antipsychotics on cognition: current issues and future challenges.
    Hill SK; Bishop JR; Palumbo D; Sweeney JA
    Expert Rev Neurother; 2010 Jan; 10(1):43-57. PubMed ID: 20021320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life in schizophrenic patients.
    Bobes J; Garcia-Portilla MP; Bascaran MT; Saiz PA; Bousoño M
    Dialogues Clin Neurosci; 2007; 9(2):215-26. PubMed ID: 17726919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substance abuse and schizophrenia: pharmacotherapeutic intervention.
    Green AI; Noordsy DL; Brunette MF; O'Keefe C
    J Subst Abuse Treat; 2008 Jan; 34(1):61-71. PubMed ID: 17574793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive predictors of skill acquisition on social problem solving in patients with schizophrenia.
    Uçok A; Cakir S; Duman ZC; Dişcigil A; Kandemir P; Atli H
    Eur Arch Psychiatry Clin Neurosci; 2006 Sep; 256(6):388-94. PubMed ID: 16783500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of functioning and well-being among individuals with schizophrenia: an integrated model.
    Yanos PT; Moos RH
    Clin Psychol Rev; 2007 Jan; 27(1):58-77. PubMed ID: 16480804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the effects of clozapine and 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on progressive ratio schedule performance: evidence against the involvement of 5-HT1A receptors in the behavioural effects of clozapine.
    Zhang Z; Rickard JF; Body S; Asgari K; Bradshaw CM; Szabadi E
    Psychopharmacology (Berl); 2005 Sep; 181(2):381-91. PubMed ID: 15830225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative analysis of the effects of some "atypical" and "conventional" antipsychotics on progressive ratio schedule performance.
    Zhang Z; Rickard JF; Asgari K; Body S; Bradshaw CM; Szabadi E
    Psychopharmacology (Berl); 2005 May; 179(2):489-97. PubMed ID: 15565430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical antipsychotics for psychosis in adolescents.
    Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
    Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of atypical antipsychotics on quality of life in patients with schizophrenia.
    Awad AG; Voruganti LN
    CNS Drugs; 2004; 18(13):877-93. PubMed ID: 15521791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluphenazine (oral) versus atypical antipsychotics for schizophrenia.
    Sampford JR; Sampson S; Li BG; Zhao S; Xia J; Furtado VA
    Cochrane Database Syst Rev; 2016 Jul; 7(7):CD010832. PubMed ID: 27370402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In the aftermath of CATIE: how should administrators value atypical antipsychotic medications?
    Luchins DJ
    Adm Policy Ment Health; 2006 Sep; 33(5):541-3. PubMed ID: 16688482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of atypical antipsychotic medications versus conventional medication.
    Hanrahan P; Luchins DJ; Fabian R; Tolley G
    Expert Opin Pharmacother; 2006 Sep; 7(13):1749-58. PubMed ID: 16925502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of atypical antipsychotic medications on psychosocial outcomes.
    Corrigan PW; Reinke RR; Landsberger SA; Charate A; Toombs GA
    Schizophr Res; 2003 Sep; 63(1-2):97-101. PubMed ID: 12892863
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.